Pennant Investors »

Enanta Pharmaceuticals shares owned by Pennant Investors

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $613k 35k 17.46

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
Morgan Stanley
Vanguard Group
BlackRock
Armistice Capital
Krensavage Asset Management
Marshall Wace
Northern Trust
Caligan Partners
Acadian Asset Management
Millennium Management
Assenagon Asset Management
Soleus Capital Management
D. E. Shaw & Co
Renaissance Technologies

View all funds holding Enanta Pharmaceuticals